Skip to main content

Table 1 The characteristics of included participants

From: The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?

Items

PCOS group (n = 62)

Control group (65)

t

p

Age

25.35 ± 3.58

25.11 ± 3.86

− 1.032

0.189

BMI (kg/m2)

24.28 ± 3.17

21.32 ± 3.29

4.205

0.018

WHR

0.90 ± 0.06

0.83 ± 0.05

1.127

0.011

LH (mIU/L)

9.03 ± 1.16

6.15 ± 1.12

1.184

0.009

FSH (IU/L)

5.96 ± 2.01

9.29 ± 2.15

1.202

0.013

TT (nmol/L)

2.28 ± 0.84

1.82 ± 0.71

1.047

0.025

SHBG (nmol/L)

32.83 ± 9.25

49.15 ± 8.19

− 12.184

0.015

FAI

9.70 ± 2.14

4.52 ± 1.18

2.105

0.029

AND (ng/mL)

3.94 ± 1.01

2.50 ± 0.96

1.146

0.012

FBG (mmol/L)

5.33 ± 1.13

4.66 ± 1.15

− 2.208

0.035

FINS (uIU/L)

23.29 ± 6.28

18.14 ± 2.24

2.995

0.000

HOMA-IR

3.92 ± 1.14

1.91 ± 0.97

1.028

0.007

TC (mmol/L)

4.86 ± 1.65

3.64 ± 1.90

1.136

0.015

TG (mmol/L)

1.43 ± 0.84

0.91 ± 0.11

1.177

0.023

HDL (mmol/L)

1.28 ± 0.22

1.32 ± 0.18

2.042

0.048

LDL (mmol/L)

2.83 ± 0.82

2.20 ± 0.74

1.192

0.017

β-trophin (pg/mL)

145.29 ± 30.22

99.30 ± 18.15

6.695

0.000

ES (μg/L)

313.09 ± 33.15

156.26 ± 28.85

20.150

0.000